KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,578 | +2.3% | 49,511 | +29.0% | 0.00% | 0.0% |
| Q2 2023 | $1,542 | +23.1% | 38,393 | +30.8% | 0.00% | 0.0% |
| Q1 2023 | $1,253 | -31.2% | 29,346 | -22.6% | 0.00% | 0.0% |
| Q4 2022 | $1,822 | -100.0% | 37,935 | -61.1% | 0.00% | -75.0% |
| Q3 2022 | $3,671,000 | +292.2% | 97,575 | +187.7% | 0.00% | +300.0% |
| Q2 2022 | $936,000 | +35.5% | 33,917 | +166.6% | 0.00% | 0.0% |
| Q1 2022 | $691,000 | – | 12,720 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,412,705 | $99,652,000 | 10.82% |
| CHI Advisors LLC | 433,852 | $30,604,000 | 8.62% |
| VR Adviser, LLC | 672,306 | $47,424,000 | 6.97% |
| Consonance Capital Management LP | 557,095 | $39,297,000 | 3.67% |
| Logos Global Management LP | 450,000 | $31,743,000 | 2.72% |
| RA Capital Management | 1,875,000 | $132,263,000 | 1.85% |
| Nantahala Capital Management | 534,514 | $37,705,000 | 1.17% |
| Orbimed Advisors | 1,679,417 | $118,466,000 | 1.04% |
| Eventide Asset Management | 346,000 | $24,407,000 | 0.37% |
| Atom Investors LP | 49,981 | $3,526,000 | 0.36% |